Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Malignant Ascites × regramostim × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 2 Stomatitis 1 Neoplasms 1 Nasopharyngeal Neoplasms 1 Malignant Ascites 1 Lung Cancer Metastatic 1

Interventions

Bevacizumab 2 regramostim 1 recombinant human tumor necrosis factor-binding protein-1 1 pembrolizumab 1 molgramostim 1 irinotecan sucrosofate 1 Paracentesis 1 Nivolumab 1 Immune Checkpoint Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05501340 2022-08-15

PD-1 Inhibitor Intraperitoneal Perfusion Combined With PRaG Therapy for Malignant Ascites

Second Affiliated Hospital of Soochow University

Phase 1/2 Unknown

Malignant Ascites

Data powered by HemOnc (CC BY 4.0) Colophon ⚡